Cytokine and chemokine profiles in women with endometriosis, polycystic ovary syndrome, and unexplained infertility

被引:7
|
作者
Omidvar-Mehrabadi, Alireza [1 ]
Ebrahimi, Fateme [1 ]
Shahbazi, Mehdi [1 ]
Mohammadnia-Afrouzi, Mousa [1 ]
机构
[1] Babol Univ Med Sci, Sch Med, Dept Immunol, Babol, Iran
关键词
Unexplained Infertility(UI); Polycystic Ovary Syndrome (PCOS); Endometriosis (EMS); Cytokines; Chemokines; ENDOTHELIAL GROWTH-FACTOR; PERITONEAL-FLUID CONCENTRATIONS; MONOCYTE CHEMOTACTIC PROTEIN-1; GAMMA-INDUCIBLE PROTEIN-10; MESSENGER-RNA EXPRESSION; IN-VITRO FERTILIZATION; NECROSIS-FACTOR-ALPHA; MATRIX METALLOPROTEINASES; INFLAMMATORY CYTOKINES; STROMAL CELLS;
D O I
10.1016/j.cyto.2024.156588
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Numerous factors (including immunological, congenital, hormonal, and morphological disorders) can lead to infertility. In this regard, 3 specific diseases associated with infertility are discussed in this review study (i.e., polycystic ovary syndrome [PCOS], endometriosis [EMS], and unexplained infertility [UI]). PCOS is a common endocrine disorder characterized by chronic low-grade inflammation, and EMS is a benign disease characterized by the presence of ectopic endometrial tissue. UI refers to couples who are unable to conceive for no known reason. Conception and pregnancy are significantly affected by the immune system; in this regard, chemokines and cytokines play important roles in the regulation of immune responses. Patients with PCOS, EMS, and UI have altered cytokine and chemokine profiles, suggesting that dysregulation of these molecules may contribute to infertility in these conditions. Accordingly, the issue of infertility is addressed in this review study, a condition that affects approximately 16% of couples worldwide.
引用
收藏
页数:15
相关论文
共 50 条
  • [1] Infertility and pregnancy in women with polycystic ovary syndrome
    Nader, S.
    MINERVA ENDOCRINOLOGICA, 2010, 35 (04) : 211 - 225
  • [2] Ovarian leukocyte distribution and cytokine/chemokine mRNA expression in follicular fluid cells in women with polycystic ovary syndrome
    Wu, R.
    Fujii, S.
    Ryan, N. K.
    Van der Hoek, K. H.
    Jasper, M. J.
    Sini, I.
    Robertson, S. A.
    Robker, R. L.
    Norman, R. J.
    HUMAN REPRODUCTION, 2007, 22 (02) : 527 - 535
  • [3] CXC chemokines influence immune surveillance in immunological disorders: Polycystic ovary syndrome and endometriosis
    Ullah, Amin
    Wang, Mei-Jiao
    Wang, Ying-Xiong
    Shen, Bairong
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2023, 1869 (05):
  • [4] Treatment of infertility in women with polycystic ovary syndrome: approach to clinical practice
    Melo, Anderson Sanches
    Ferriani, Rui Alberto
    Navarro, Paula Andrea
    CLINICS, 2015, 70 (11) : 765 - 769
  • [5] The Complex Roles of Adipokines in Polycystic Ovary Syndrome and Endometriosis
    Schueler-Toprak, Susanne
    Ortmann, Olaf
    Buechler, Christa
    Treeck, Oliver
    BIOMEDICINES, 2022, 10 (10)
  • [6] Incorporating patient preference into the management of infertility in women with polycystic ovary syndrome
    Okoroafor, Ugochi C.
    Jungheim, Emily S.
    PATIENT PREFERENCE AND ADHERENCE, 2012, 6 : 407 - 415
  • [8] Endometriosis and polycystic ovary syndrome are diametric disorders
    Dinsdale, Natalie L.
    Crespi, Bernard J.
    EVOLUTIONARY APPLICATIONS, 2021, 14 (07): : 1693 - 1715
  • [9] Immunophenotypic Profiles in Polycystic Ovary Syndrome
    Hu, Cong
    Pang, Bo
    Ma, Zhanchuan
    Yi, Huanfa
    MEDIATORS OF INFLAMMATION, 2020, 2020
  • [10] Immunological and Metabolic Causes of Infertility in Polycystic Ovary Syndrome
    Kicinska, Aleksandra Maria
    Maksym, Radoslaw B.
    Zabielska-Kaczorowska, Magdalena A.
    Stachowska, Aneta
    Babinska, Anna
    BIOMEDICINES, 2023, 11 (06)